drugset / Trial / NCT01524939
Study of Combined Therapy of Aspirin and "IVIG-SN" in Kawasaki Disease
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety, efficacy and of Immune Globulin Intravenous (Human) IVIG-SN™ in subjects with kawasaki diseases.
Timeline
- Start
- 2012-01
- Primary completion
- 2012-09
- Completion
- 2012-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Immunoglobulin G | Protein / enzyme biologic | 2 g/kg | Intravenous |